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Abstract 
This study was conducted to determine the prevalence and distribution of urogenital Chlamydia trachomatis geno-
types in symptomatic male patients who were referred to the clinics of the Istanbul Faculty of Medicine. Of 419 uro-
genital swabs, 57 samples (13.6 %) were positive for C. trachomatis. Genotype distribution of C. trachomatis-positive 
samples identified five genetic variants namely genotype E as the most prevalent (36.4 %), followed by genotype G 
(23.6 %), H (21.8 %), D (16.4 %) and F (1.8 %). We believe that this is the first study on distribution of genotypes of C. 
trachomatis genital infections in symptomatic men in Istanbul, Turkey.
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Background
Chlamydia trachomatis (C. trachomatis) is an obligate 
intracellular bacterial pathogen, which continues to be 
the most commonly reported sexually transmitted bacte-
rial infection and causes substantial morbidity and eco-
nomic loss worldwide (WHO 2008). In 2008, the World 
Health Organization forecasted 106 million new urogeni-
tal chlamydia cases annually among the adult population 
globally. Compared to the majority of sexually transmit-
ted infections (STIs), C. trachomatis infection is still the 
most frequently reported STI with 384.555 cases of C. 
trachomatis infection recorded in EU countries in 2013 
(ECDC 2015). The prevalence of different serovars are 
indicators of the circulating C. trachomatis serovars in 
different geographical locations (Lysen et  al. 2004). The 
connection between urogenital serovars and clinical 
manifestations is still inconclusive. While a direct cor-
relation between clinical symptoms and certain serovars 
was found in some studies (Morre et al. 2000), no asso-
ciation was found between urogenital infections and 
serovars in others (Lysen et  al. 2004). Currently, there 
are 19 identified human serovars and related variants 
(A, B/Ba, C, D/Da, E, F, G, Ga, H, I/Ia, J, K, L1, L2, L2a 
and L3) which are classified based on the antigenic vari-
ations of the major outer membrane protein (MOMP) 
(Morre et  al. 2000). C. trachomatis serovars A, B/Ba 
and C cause conjunctival infections and are related with 
ocular disease. Serotypes D/Da, E, F, G, Ga, H, I/Ia, J, K 
cause urogenital infections, and serovars L1, L2 and L3 
are responsible for lymphogranuloma venereum (LGV) 
(Manavi 2006). The distribution of C. trachomatis geno-
types have been identified in several countries of the 
world (Lysen et al. 2004; Taheri Beni et al. 2010; Millman 
et al. 2004; Ngandjio et al. 2003; Gallo Vaulet et al. 2010; 
Yang et al. 2010) and being predominant with the geno-
type E (26–46  %), D (9–20  %) and F (14–24  %) in uro-
genital infections. Another study, in which samples were 
collected from countries in different geographical loca-
tions showed that C. trachomatis E (45  %), F (16  %), D 
(13 %), G (10 %) and K (%5,8) genotypes were reported as 
the most frequently detected genotypes in heterosexual 
patients (Herrmann et al. 2015).
A high resolution melting analysis (HRMA) method for 
cervical and urethral swabs has recently been developed 
for genotyping of the omp1 gene, which encodes MOMP 
(Li et al. 2010).
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The prevalence of genital chlamydial infection in sym-
tomatic men in different regions of Turkey was reported 
in few studies and varied between 10.5 and 23 % and was 
found to be at rates comparable to those of European 
countries (Agacfidan et al. 2001; Aslan et al. 2002; Kaleli 
et al. 1999). But so far, no data exists on the circulating 
genotype distribution in Turkey. The aim of this study 
was to determine and characterize the prevalence of C. 
trachomatis genotypes on symptomatic male patients 
attending a STD clinic in Istanbul University Faculty of 
Medicine by HRMA and sanger sequencing.
Methods
Patients
A total of 419 urogenital swab specimen were collected 
from male patients (aged 18–68) with symptoms (dis-
charge, pain during urination, genito-urinary pain during 
sexual intercourse) for the investigation of STDs. Writ-
ten informed consent for participation in this study was 
obtained from all participants. The authors assert that all 
procedures contributing to this work were approved by 
the Ethics Committee of Istanbul University (reference 
number 2015/1244), comply with the ethical standards 
on human experimentation and with the Helsinki Decla-
ration of 1975, as revised in 2008. The swabs were placed 
in medium for Chlamydia PCR and were stored at 4  °C 
until transportation to the laboratory and then stored at 
−20 °C until real time PCR for C. trachomatis DNA was 
performed.
Real time PCR analysis of C.trachomatis DNA
DNA was prepared from urogenital samples using high 
pure PCR template preparation kit (Roche Diagnostics 
GmBH, Mannheim Germany) and suspended in 200  µl 
elution buffer according to the manufacturer’s proto-
cols (Morre et  al. 1998).After quantification of isolated 
DNA, probes were studied according to the manufac-
turer’s instructions on Light Cycler 2.0 (Roche Diag-
nostics GmBH, Mannheim Germany) instrument. The 
master mix for C. trachomatis DNA real time PCR reac-
tions were prepared using LightCycler® Fast Start DNA 
Master HybProbe kit (Roche Diagnostics GmBH, Man-
nheim, Germany) and Lightmix C. trachomatis kit (TIB 
Molbiol GmBH, Berlin, Germany). 5 µl of template DNA 
were added to each capillary tube for a final reaction vol-
ume of 20 µl. One negative and one positive control were 
included in each run. The PCR profile was an initial dena-
turation of template and activation of enzyme at 95 °C for 
10 min followed by 50 cycles of 95  °C for 5  s, 62  °C for 
5  s, and 72  °C for 15  s. Data analysis was performed as 
described in the LightCycler instrument operator’s man-
ual. The criteria used for determining positive and nega-
tive samples depended on the amplification curves at a 
wavelength of 640 nm. C.trachomatis positive DNAs and 
samples were stored at −70 °C for further analysis.
HRM analysis
The external primers for the VS1–VS2 PCR were CT1: 
5′-TGA ACC AAG CCT TAT GAT CGA CGG A-3′ and 
CT2: 5′-CGG AAT TGT GCA TTT ACG TGA G-3′. 
The internal PCR primers were selected as previously 
described by Zheng et al. (2007) and were CT3: 5′-ACT 
TTG TTT TCG ACC GTG TTT TG-3′ and CT4: 5′-GAT 
TGA GCG TATTGG AAA GAA GC-3′. All primers 
were synthesized from IDT (Integrated DNA Technolo-
gies, Coraville, Iowa). C.trachomatis positive DNA sam-
ples were amplified in 96-well plates. LightCycler 480 
High Resolution Master kit (Roche Diagnostics GmBH, 
Mannheim Germany) was used for HRM analysis in a 
LightCycler 480 II system (Roche Diagnostics GmBH, 
Mannheim Germany). In brief, each reaction was per-
formed in a final volume of 10  μl containing 20  ng of 
DNA, 0.25 mM of each primer (forward or reverse) and 
1 × LightCycler 480 HRM Master mix (Roche). The PCR 
profile was: an initial denaturation of template and activa-
tion of enzyme at 95 °C for 10 min followed by 40 cycles 
of 95 °C for 10 s, 57 °C for 10 s, and 72 °C for 20 s. At the 
end of the PCR cycles, PCR products were denatured at 
95 °C for 1 min and rapidly cooled to 40 °C. HRM anal-
yses were performed from 72  °C  to 95  °C at a tempera-
ture gradient of 1 °C/sec, acquiring 25 data points per °C. 
Each sample was run in duplicate for analysis. All sam-
ples were grouped by the LightCycler 480 Gene Scanning 
Software.
Sequencing of the omp1 gene
DNA from C. trachomatis-positive samples was purified 
using the Qiaquick PCR Purification Kit (Qiagen, Hilden, 
Germany) as instructed by the manufacturer. The omp1 
gene was sequenced using the Big Dye Sequencing Ter-
minator Kit and ABI 3130×l sequencing system (Applied 
Biosystems, Foster City, CA, USA) with HRMA VS-1 and 
VS-2 primers. The strains with corresponding accession 
numbers B/IU-1226 (AF063208), B/B-16 (AY950630), 
D/B-120 (X62918), Da/TW-448 (X62921), E/Bour 
(X52557), F/ICCal3 (X52080), G/UW57 (AF063199), H/
Wash (H/UW4) (X16007), I/UW12 (AF063200),J/UW36 
(AF063202) and K/UW31 (AF063204) were used as ref-
erence sequences. The omp1 sequences were edited, 
aligned, and analysed using the MEGA6 software.
Statistical analysis
Statistical analysis was performed using the Chi square 
test and IBM SPSS version 20 software (IBM  Corpo-
ration, Armonk, NY, USA) for establish relationship 
between C.trachomatis prevalence and patient’s age.
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Results and discussion
A total of 419 urogenital swab specimen from sympto-
matic male patients were studied for C. trachomatis. 57 
out of these 419 samples (13.6 %) were DNA positive for 
C. trachomatis (Table 1). This prevalence rate of C. tra-
chomatis in symptomatic men lies within the previously 
detected range in other turkish epidemiological stud-
ies (Agacfidan et al. 2001; Aslan et al. 2002; Kaleli et al. 
1999). The largest proportion of cases in European coun-
tries reported in 2013 were among young people between 
20 and 24 of age who accounted for 41  % of cases. The 
second largest group was the age group of 15–19  years 
old accounting for 26 % (ECDC 2015). However, in com-
parison to the age-related infection rates of European 
countries with the highest Chlamydia prevalence among 
persons with 15–24 of age, rates in our study were found 
to peak in the age group 20–29 (χ2 = 35,587, p < 0,001). 
The reason is suggested to be the older age at onset of 
sexual activity in Turkey when compared to European 
countries.
The genotypes of the 57 C. trachomatis-positive sam-
ples were analysed by HRMA and a total of 55 omp1 frag-
ments could successfully be amplified. After the HRM 
group analysis we discriminated 5 genotype clusters in 
our materials (Fig.  1) and chose two different samples 
from each genotypes cluster for sequencing of the omp1 
gene. The five C. trachomatis genotypes were identified to 
be genotype E (n = 20, 36.4 %) as the most prevalent, fol-
lowed by G (n = 13, 23.6 %), H (n = 12, 21.8 %), D (n = 9, 
16.4 %) and F (n = 1, 1.8 %) (Table 2). The predominance 
of genotype E is in line with previous studies on differ-
ent patient groups (Taheri Beni et  al.  2010, Ngandjio 
et al. 2003, Gallo Vaulet et al. 2010, Mejuto et al. 2013). 
Genotypes E, F and D are known to be the most prevalent 
genotypes circulating in heterosexual populations world-
wide (Lysen et al. 2004; Taheri Beni et al. 2010; Millman 
et al. 2004; Ngandjio et al. 2003; Gallo Vaulet et al. 2010; 
Yang et al. 2010). An unusual finding of this study was the 
relatively high prevalence (23.6 %) of genotype G in our 
cohort. This genotype has widely been reported for the 
population of men having sex with men in European and 
other countries (Li et al. 2011; Mejuto et al. 2013; Quint 
et al. 2011; Twin et al. 2011). The high genotype G rates 
in our study might suggest a high number of men among 
the analyzed patients who have sex with men. Genotype 
H showed the highest frequency (72.7 %) in male patients 
in the age group 30–34. Interestingly, C.trachomatis gen-
otypes J,K and I/Ia found in male patients in other reports 
(Lysen et al. 2004; Millman et al. 2004; Herrmann et al. 
2015), were not detected in our study, which may indicate 
a specific geographical distribution of certain genotypes. 
On the other hand the number of samples included in 
the analysis was relatively small and genotypes with low 
prevalence rates might have been missed. 
In conclusion, we detected five different C.trachomatis 
genotypes among our patients. This diversity might be 
associated with sexual behavior among different religious 
and ethnic groups living in Istanbul. We believe that this 
Table 1 Prevalence of cervical C. trachomatis infection in different age groups as determined by real-time PCR
Age group <20 20–24 25–29 30–34 35–44 +45
PCR + 2 (50 %) 17 (34 %) 17 (15.9 %) 12 (16.4 %) 7 (6.1 %) 2 (2.9 %) 57 (13.6 %)
PCR - 2 (50 %) 33 (66 %) 90 (84.1 %) 61 (83.6 %) 108 (93.9 %) 68 (97.1 %) 362 (86.4 %)
Total 4 50 107 73 115 70 419
Fig. 1 Identification of five different STI-related C. trachomatis genotypes by gene scanning and genotyping analysis. Genotype specific curves 
were distinguishable and could be differentiated through direct visualization (green genotype E, red genotype D; blue genotype G, pink genotype H, 
yellow genotype F)
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is the first study investigating the prevalence and distri-
bution of genotypes of C. trachomatis genital infections 
of symptomatic men in Istanbul, Turkey.
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